This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bakry, N. M. Articles by Simpson, L. L. Search for Related Content PubMed PubMed Citation Articles by Bakry, N. M. Articles by Simpson, L. L.

 Previous Article  |  Next Article 

Infect. Immun., Jun 1997, 2225-2232, Vol 65, No. 6
Copyright © 1997, American Society for Microbiology

Expression of botulinum toxin binding sites in Xenopus oocytes

NM Bakry, Y Kamata and LL Simpson
Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.

The binding of iodinated botulinum toxin type B to nerve membranes was studied by using rat and mouse preparations. The toxin was examined both in the single-chain and in the proteolytically processed dichain form, and binding sites both in the spinal cord and in various brain regions were assayed. Rat and mouse brains possessed specific binding sites for botulinum toxin type B. The average Kd values for the various rat and mouse membrane preparations examined were 4.2 +/- 0.7 nM and 3.7 +/- 0.9 nM, respectively. The average Bmax values for the same tissue preparations were 7.3 +/- 0.7 pmol/mg of protein and 7.5 +/- 1.9 pmol/mg protein, respectively. The binding of botulinum toxin type B to rat brain membranes was not antagonized by a polyclonal antibody against the cytosolic domain of synaptotagmin 1 or by a monoclonal antibody directed against the luminal domain of synaptotagmin 1. In addition, these antibodies did not protect the mouse phrenic nerve- hemidiaphragm from toxin-induced neuromuscular blockade. Extraction of whole-brain mRNA and injection into Xenopus oocytes led to expression of binding sites for botulinum toxin. Extraction and injection of cerebellar mRNA led to expression of a higher density of binding sites. The number of binding sites was not diminished when oocytes were pretreated with antibodies against the cytosolic and luminal domains of synaptotagmin 1. These findings are likely to aid in the isolation, characterization, and reconstitution of toxin binding sites.

This article has been cited by other articles:

• Herreros, J., Ng, T., Schiavo, G. (2001). Lipid Rafts Act as Specialized Domains for Tetanus Toxin Binding and Internalization into Neurons. Mol. Biol. Cell 12: 2947-2960 [Abstract] [Full Text]  
• Coffield, J. A., Bakry, N. M., Maksymowych, A. B., Simpson, L. L. (1999). Characterization of a Vertebrate Neuromuscular Junction That Demonstrates Selective Resistance to Botulinum Toxin. J. Pharmacol. Exp. Ther. 289: 1509-1516 [Abstract] [Full Text]  
• Lalli, G, Herreros, J, Osborne, S., Montecucco, C, Rossetto, O, Schiavo, G (1999). Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell Sci. 112: 2715-2724 [Abstract]